Literature DB >> 23560675

The costs of transfusion: economic evaluations in transfusion medicine, Part 1.

Seema Kacker1, Kevin D Frick, Aaron A R Tobian.   

Abstract

Mesh：

Year:  2013        PMID： 23560675     DOI： 10.1111/trf.12188

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  6 in total

1.  Patient Blood Management in Italy.

Authors:  Ranieri Guerra; Claudio Velati; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

2.  The impact of external donor support through the U.S. President's Emergency Plan for AIDS Relief on the cost of red cell concentrate in Namibia, 2004-2011.

Authors:  John P Pitman; Adele Bocking; Robert Wilkinson; Maarten J Postma; Sridhar V Basavaraju; Bjorn von Finckenstein; Mary Mataranyika; Anthony A Marfin; David W Lowrance; Cees Th Smit Sibinga
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 3.  Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Authors:  Eric A Gehrie; Paul M Ness; Evan M Bloch; Seema Kacker; Aaron A R Tobian
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

4.  Reducing the Time to Blood Administration after Pediatric Injury: A Quality Improvement Initiative.

Authors:  Travis M Sullivan; Zachary P Milestone; Emily C Alberto; Elizabeth M Waibel; Waverly V Gestrich-Thompson; Peyton E Tempel; Jennifer L Fritzeen; Karen J O'Connell; Jacob Cheng; Randall S Burd
Journal:  Pediatr Qual Saf       Date:  2022-06-14

5.  Reducing unnecessary preoperative blood orders and costs by implementing an updated institution-specific maximum surgical blood order schedule and a remote electronic blood release system.

Authors:  Steven M Frank; Michael J Oleyar; Paul M Ness; Aaron A R Tobian
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

6.  Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2014-02-27       Impact factor: 3.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.